Loading clinical trials...
Loading clinical trials...
The study aims to provide initial PoC validation data of two AI models to predict disease progression and treatment side effects in PD patients using as input patients' demographic, clinical and genet...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Toulouse
Collaborators
NCT07478146 · PARKINSON DISEASE (Disorder)
NCT07467460 · PARKINSON DISEASE (Disorder), Alzheimer s Disease, and more
NCT07422675 · PARKINSON DISEASE (Disorder), Advanced Parkinson's Disease
NCT07217054 · PARKINSON DISEASE (Disorder), Parkinson, and more
NCT07360977 · PARKINSON DISEASE (Disorder), Multiple Sclerosis (MS) - Relapsing-remitting, and more
University Hospital of Toulouse
Toulouse
Technische Universität Dresden
Dresden
Hospital Ruber Internacional
Madrid
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions